Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials
Authors
Keywords
-
Journal
International Journal of Stroke
Volume -, Issue -, Pages 174749301879002
Publisher
SAGE Publications
Online
2018-07-23
DOI
10.1177/1747493018790024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
- (2018) Bruce C.V. Campbell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
- (2018) Mahesh Kate et al. Journal of Stroke
- Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
- (2017) Werner Hacke et al. International Journal of Stroke
- Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
- (2017) Nicola Logallo et al. LANCET NEUROLOGY
- Tenecteplase in ischemic stroke offers improved recanalization
- (2017) Andrew Bivard et al. NEUROLOGY
- Too good to treat? ischemic stroke patients with small computed tomography perfusion lesions may not benefit from thrombolysis
- (2016) Andrew Bivard et al. ANNALS OF NEUROLOGY
- Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic StrokeClinical Perspective
- (2016) Andrew Bivard et al. CIRCULATION
- Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials
- (2016) Xuya Huang et al. International Journal of Stroke
- Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
- (2016) William N Whiteley et al. LANCET NEUROLOGY
- Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke
- (2016) Rüdiger von Kummer et al. STROKE
- Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
- (2016) Grant Mair et al. STROKE
- Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes
- (2016) Kennedy R. Lees et al. STROKE
- Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study
- (2015) Xuya Huang et al. LANCET NEUROLOGY
- Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
- (2015) Gregory W Albers et al. LANCET NEUROLOGY
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
- (2015) Mayank Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
- (2015) Bruce C.V. Campbell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
- (2015) Olvert A. Berkhemer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tenecteplase–Tissue-Type Plasminogen Activator Evaluation for Minor Ischemic Stroke With Proven Occlusion
- (2015) Shelagh B. Coutts et al. STROKE
- Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke
- (2015) Xuya Huang et al. STROKE
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
- (2014) Jonathan Emberson et al. LANCET
- Presentation and Outcomes of “Wake-Up Strokes” in a Large Randomized Stroke Trial: Analysis of Data from the International Stroke Trial
- (2012) Yogesh Moradiya et al. Journal of Stroke & Cerebrovascular Diseases
- A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
- (2012) Mark Parsons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection
- (2012) Steven Warach et al. STROKE
- Vascular Occlusion Enables Selecting Acute Ischemic Stroke Patients for Treatment With Desmoteplase
- (2012) Jochen B. Fiebach et al. STROKE
- Timing of Recanalization After Intravenous Thrombolysis and Functional Outcomes After Acute Ischemic Stroke
- (2012) Leonard L. L. Yeo et al. JAMA Neurology
- Population-based study of wake-up strokes
- (2011) J. Mackey et al. NEUROLOGY
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
- (2010) Kennedy R Lees et al. LANCET
- Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke
- (2010) Rohit Bhatia et al. STROKE
- Thrombolysis Is Associated With Consistent Functional Improvement Across Baseline Stroke Severity
- (2010) Nishant K. Mishra et al. STROKE
- Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke
- (2010) E. Clarke Haley et al. STROKE
- Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window
- (2009) M. W. Parsons et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started